Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY12.66 CNY
Change Today -0.20 / -1.56%
Volume 15.3M
000650 On Other Exchanges
As of 10:36 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

renhe pharmacy co ltd-a (000650) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - CNY14.38
52 Week Low
06/24/14 - CNY4.58
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RENHE PHARMACY CO LTD-A (000650)

Related News

No related news articles were found.

renhe pharmacy co ltd-a (000650) Related Businessweek News

No Related Businessweek News Found

renhe pharmacy co ltd-a (000650) Details

Renhe Pharmacy Co., Ltd operates in the pharmaceutical industry in China. The company produces and sells medicine, bulk drugs, and health-related products, including oral solid dosage, oral liquid preparations, injections, topical lotions, liniments, suppositories, and ointments, as well as other forms of drugs. It is also engaged in the wholesale and retail of related pharmaceuticals and healthcare products. The company’s principal products include Compound Paracetamol and Amantadine Hydrochloride capsules, which are used to treat common cold; Miconazole Nitrate cream that is used to cure skin disease and gynopathy; and Pediatric Paracetamol and Amantadine Hydrochloride granules, which are used for the prevention and treatment of children's influenza. Renhe Pharmacy Co., Ltd is based in Beijing, China.

renhe pharmacy co ltd-a (000650) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

renhe pharmacy co ltd-a (000650) Key Developments

Renhe Pharmacy Co., Ltd to Report Fiscal Year 2014 Results on Apr 25, 2015

Renhe Pharmacy Co., Ltd announced that they will report fiscal year 2014 results on Apr 25, 2015

Renhe Pharmacy Co., Ltd. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 2014

Renhe Pharmacy Co. Ltd. provided earnings guidance for the fourth quarter and full year ended December 2014. The company expected net profit attributable to shareholders of CNY 291.2743 million to CNY 330.1108 million in 2014, rising 50% to 70% from a year earlier. Net profit attributable to shareholders will be CNY 91.0871 million to CNY 129.9236 million in October-December period, jumping 625.51% to 934.84%. Basic EPS will be CNY 0.294 to CNY 0.3332 for 2014, in contrast to CNY 0.196 a year ago. The increasing operating revenue and net profit in the fourth quarter has boosted performance for the 2014 full year.

Renhe Pharmacy Co., Ltd Approves Amendments to its Articles of Association

Renhe Pharmacy Co. Ltd. approved amendments to its articles of association at its EGM held on December 26, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000650:CH CNY12.66 CNY -0.20

000650 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000650.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000650 Industry Range
Price/Earnings 42.8x
Price/Sales 5.9x
Price/Book 6.3x
Price/Cash Flow 42.3x
TEV/Sales 5.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RENHE PHARMACY CO LTD-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at